Original language | English |
---|---|
Pages (from-to) | 1474-1477.e2 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 133 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2014 |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Allergy and Clinical Immunology, Vol. 133, No. 5, 2014, p. 1474-1477.e2.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes
AU - Nagasaki, Tadao
AU - Matsumoto, Hisako
AU - Kanemitsu, Yoshihiro
AU - Izuhara, Kenji
AU - Tohda, Yuji
AU - Kita, Hideo
AU - Horiguchi, Takahiko
AU - Kuwabara, Kazunobu
AU - Tomii, Keisuke
AU - Otsuka, Kojiro
AU - Fujimura, Masaki
AU - Ohkura, Noriyuki
AU - Tomita, Katsuyuki
AU - Yokoyama, Akihito
AU - Ohnishi, Hiroshi
AU - Nakano, Yasutaka
AU - Oguma, Tetsuya
AU - Hozawa, Soichiro
AU - Ito, Isao
AU - Oguma, Tsuyoshi
AU - Inoue, Hideki
AU - Tajiri, Tomoko
AU - Iwata, Toshiyuki
AU - Izuhara, Yumi
AU - Ono, Junya
AU - Ohta, Shoichiro
AU - Yokoyama, Tetsuji
AU - Niimi, Akio
AU - Mishima, Michiaki
N1 - Funding Information: Disclosure of potential conflict of interest: K. Izuhara has received research support from Shino-test Co Ltd, has received research support and personal fees from Chugai Pharmacological Co Ltd and from Aqua Theraputics Co Ltd, has been supported by Hoffmann-La Roche Co Ltd, and has a patent entitled “Usefulness of periostin measurement in bronchial asthma.” A. Yokoyama has received personal fees from Novartis Pharma, Astellas Pharma, Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline. T. Oguma has received personal fees from GlaxoSmithKline and AstraZeneca. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was funded by Kinki Hokuriku Airway disease Conference (KiHAC), as a project of the 2009 KiHAC Respiratory Medicine Group and the Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST .
PY - 2014
Y1 - 2014
UR - http://www.scopus.com/inward/record.url?scp=84899625250&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899625250&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2013.12.1084
DO - 10.1016/j.jaci.2013.12.1084
M3 - Article
C2 - 24582168
AN - SCOPUS:84899625250
SN - 0091-6749
VL - 133
SP - 1474-1477.e2
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 5
ER -